The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Perturbations in PI3K pathway and cyclin dependent kinase (CDK) pathway to predict complete responders in CRC patients treated with ADAPT therapy.
Edward H. Lin
No relevant relationships to disclose
Xiaowei Yan
No relevant relationships to disclose
John Dallas Scarborough
No relevant relationships to disclose
David Wu
No relevant relationships to disclose
Jing Tang
No relevant relationships to disclose
Lingheng Li
No relevant relationships to disclose
Douglas E. Wood
No relevant relationships to disclose
Shilpen A. Patel
No relevant relationships to disclose
Edward Y. Kim
No relevant relationships to disclose
Raymond Sze Yeung
No relevant relationships to disclose
Jonathan F. Tait
No relevant relationships to disclose
Colin C. Pritchard
No relevant relationships to disclose
Qiang Tian
No relevant relationships to disclose